Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60


IL-7-dependent STAT1 activation limits homeostatic CD4+ T cell expansion.

Le Saout C, Luckey MA, Villarino AV, Smith M, Hasley RB, Myers TG, Imamichi H, Park JH, O'Shea JJ, Lane HC, Catalfamo M.

JCI Insight. 2017 Nov 16;2(22). pii: 96228. doi: 10.1172/jci.insight.96228. eCollection 2017 Nov 16.


STING is an essential mediator of the Ku70-mediated production of IFN-λ1 in response to exogenous DNA.

Sui H, Zhou M, Imamichi H, Jiao X, Sherman BT, Lane HC, Imamichi T.

Sci Signal. 2017 Jul 18;10(488). pii: eaah5054. doi: 10.1126/scisignal.aah5054.


Interleukin-27 Enhances the Potential of Reactive Oxygen Species Generation from Monocyte-derived Macrophages and Dendritic cells by Induction of p47phox.

Sowrirajan B, Saito Y, Poudyal D, Chen Q, Sui H, DeRavin SS, Imamichi H, Sato T, Kuhns DB, Noguchi N, Malech HL, Lane HC, Imamichi T.

Sci Rep. 2017 Feb 27;7:43441. doi: 10.1038/srep43441.


Rapid Recall Ability of Memory T cells is Encoded in their Epigenome.

Barski A, Cuddapah S, Kartashov AV, Liu C, Imamichi H, Yang W, Peng W, Lane HC, Zhao K.

Sci Rep. 2017 Jan 5;7:39785. doi: 10.1038/srep39785.


Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.

Imamichi H, Dewar RL, Adelsberger JW, Rehm CA, O'Doherty U, Paxinos EE, Fauci AS, Lane HC.

Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8783-8. doi: 10.1073/pnas.1609057113. Epub 2016 Jul 18.


CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.

Migueles SA, Mendoza D, Zimmerman MG, Martins KM, Toulmin SA, Kelly EP, Peterson BA, Johnson SA, Galson E, Poropatich KO, Patamawenu A, Imamichi H, Ober A, Rehm CA, Jones S, Hallahan CW, Follmann DA, Connors M.

EBioMedicine. 2014 Dec 22;2(1):46-58. doi: 10.1016/j.ebiom.2014.12.009. eCollection 2015 Jan.


Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.

Huang J, Kang BH, Pancera M, Lee JH, Tong T, Feng Y, Imamichi H, Georgiev IS, Chuang GY, Druz A, Doria-Rose NA, Laub L, Sliepen K, van Gils MJ, de la Peña AT, Derking R, Klasse PJ, Migueles SA, Bailer RT, Alam M, Pugach P, Haynes BF, Wyatt RT, Sanders RW, Binley JM, Ward AB, Mascola JR, Kwong PD, Connors M.

Nature. 2014 Nov 6;515(7525):138-42. doi: 10.1038/nature13601. Epub 2014 Sep 3.


Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis.

Le Saout C, Hasley RB, Imamichi H, Tcheung L, Hu Z, Luckey MA, Park JH, Durum SK, Smith M, Rupert AW, Sneller MC, Lane HC, Catalfamo M.

PLoS Pathog. 2014 Mar 6;10(3):e1003976. doi: 10.1371/journal.ppat.1003976. eCollection 2014 Mar.


Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.

Sereti I, Estes JD, Thompson WL, Morcock DR, Fischl MA, Croughs T, Beq S, Lafaye de Micheaux S, Yao MD, Ober A, Wilson EM, Natarajan V, Imamichi H, Boulassel MR, Lederman MM, Routy JP.

PLoS Pathog. 2014 Jan 30;10(1):e1003890. doi: 10.1371/journal.ppat.1003890. eCollection 2014 Jan.


Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus.

Imamichi H, Natarajan V, Adelsberger JW, Rehm CA, Lempicki RA, Das B, Hazen A, Imamichi T, Lane HC.

AIDS. 2014 May 15;28(8):1091-9. doi: 10.1097/QAD.0000000000000223.


Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis.

Falcone EL, Adegbulugbe AA, Sheikh V, Imamichi H, Dewar RL, Hammoud DA, Sereti I, Lane HC.

Clin Infect Dis. 2013 Sep;57(5):e135-42. doi: 10.1093/cid/cit356. Epub 2013 May 31.


Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.

Hurley A, Smith M, Karpova T, Hasley RB, Belkina N, Shaw S, Balenga N, Druey KM, Nickel E, Packard B, Imamichi H, Hu Z, Follmann D, McNally J, Higgins J, Sneller M, Lane HC, Catalfamo M.

J Infect Dis. 2013 Feb 15;207(4):638-50. doi: 10.1093/infdis/jis730. Epub 2012 Nov 29.


Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.

Huang J, Ofek G, Laub L, Louder MK, Doria-Rose NA, Longo NS, Imamichi H, Bailer RT, Chakrabarti B, Sharma SK, Alam SM, Wang T, Yang Y, Zhang B, Migueles SA, Wyatt R, Haynes BF, Kwong PD, Mascola JR, Connors M.

Nature. 2012 Nov 15;491(7424):406-12. doi: 10.1038/nature11544. Epub 2012 Sep 18.


The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls.

Imamichi H, Lempicki RA, Adelsberger JW, Hasley RB, Rosenberg A, Roby G, Rehm CA, Nelson A, Krishnan S, Pavlick M, Woods CJ, Baseler MW, Lane HC.

Eur J Immunol. 2012 Oct;42(10):2608-20. doi: 10.1002/eji.201142046. Epub 2012 Aug 6.


Regulatory T cells in HIV-1 infection: the good, the bad, and the ugly.

Imamichi H, Lane HC.

J Infect Dis. 2012 May 15;205(10):1479-82. doi: 10.1093/infdis/jis238. Epub 2012 Mar 28. No abstract available.


Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia.

Puronen CE, Thompson WL, Imamichi H, Beq S, Hodge JN, Rehm C, Parker R, DerSimonian R, Brenchley JM, Sereti I.

J Infect Dis. 2012 May 1;205(9):1382-90. doi: 10.1093/infdis/jis219. Epub 2012 Mar 26.


Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site.

Wu X, Wang C, O'Dell S, Li Y, Keele BF, Yang Z, Imamichi H, Doria-Rose N, Hoxie JA, Connors M, Shaw GM, Wyatt RT, Mascola JR.

J Virol. 2012 May;86(10):5844-56. doi: 10.1128/JVI.07139-11. Epub 2012 Mar 14.


Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments.

Imamichi H, Degray G, Dewar RL, Mannon P, Yao M, Chairez C, Sereti I, Kovacs JA.

J Infect Dis. 2011 Jul 15;204(2):309-14. doi: 10.1093/infdis/jir259.


Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN.

Zhang X, Brann TW, Zhou M, Yang J, Oguariri RM, Lidie KB, Imamichi H, Huang DW, Lempicki RA, Baseler MW, Veenstra TD, Young HA, Lane HC, Imamichi T.

J Immunol. 2011 Apr 15;186(8):4541-5. doi: 10.4049/jimmunol.1003389. Epub 2011 Mar 11.


HIV-1 infected monozygotic twins: a tale of two outcomes.

Tazi L, Imamichi H, Hirschfeld S, Metcalf JA, Orsega S, Pérez-Losada M, Posada D, Lane HC, Crandall KA.

BMC Evol Biol. 2011 Mar 8;11:62. doi: 10.1186/1471-2148-11-62.


HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy.

Imamichi H, Degray G, Asmuth DM, Fischl MA, Landay AL, Lederman MM, Sereti I.

AIDS. 2011 Jan 14;25(2):159-64. doi: 10.1097/QAD.0b013e328340a270.


Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.

Imamichi H, Koita O, Dabitao D, Dao S, Ibrah M, Sogoba D, Dewar RL, Berg SC, Jiang MK, Parta M, Washington JA, Polis MA, Lane HC, Tounkara A.

AIDS Res Hum Retroviruses. 2009 Jan;25(1):45-55. doi: 10.1089/aid.2008.0111.


IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3.

Imamichi H, Sereti I, Lane HC.

Eur J Immunol. 2008 Jun;38(6):1621-30. doi: 10.1002/eji.200737607.


CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation.

Sereti I, Sklar P, Ramchandani MS, Read SW, Aggarwal V, Imamichi H, Natarajan V, Metcalf JA, Kovacs JA, Tavel J, Davey RT, Dersimonian R, Lane HC.

J Infect Dis. 2007 Sep 1;196(5):677-83. Epub 2007 Jul 16.


Although macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques.

Igarashi T, Donau OK, Imamichi H, Nishimura Y, Theodore TS, Iyengar R, Erb C, Buckler-White A, Buckler CE, Martin MA.

J Virol. 2007 Oct;81(19):10669-79. Epub 2007 Jul 11.


Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques.

Nishimura Y, Igarashi T, Buckler-White A, Buckler C, Imamichi H, Goeken RM, Lee WR, Lafont BA, Byrum R, Lane HC, Hirsch VM, Martin MA.

J Virol. 2007 Jan;81(2):893-902. Epub 2006 Nov 8.


In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.

Sereti I, Imamichi H, Natarajan V, Imamichi T, Ramchandani MS, Badralmaa Y, Berg SC, Metcalf JA, Hahn BK, Shen JM, Powers A, Davey RT, Kovacs JA, Shevach EM, Lane HC.

J Clin Invest. 2005 Jul;115(7):1839-47. Epub 2005 Jun 2.


Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.

Igarashi T, Donau OK, Imamichi H, Dumaurier MJ, Sadjadpour R, Plishka RJ, Buckler-White A, Buckler C, Suffredini AF, Lane HC, Moore JP, Martin MA.

J Virol. 2003 Dec;77(24):13042-52.


The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.

Igarashi T, Imamichi H, Brown CR, Hirsch VM, Martin MA.

J Leukoc Biol. 2003 Nov;74(5):772-80.


The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.

Migueles SA, Laborico AC, Imamichi H, Shupert WL, Royce C, McLaughlin M, Ehler L, Metcalf J, Liu S, Hallahan CW, Connors M.

J Virol. 2003 Jun;77(12):6889-98.


[Research on factors for dropout from treatment by outpatients of alcohol abuse or alcohol dependence (II)--Based on questionnaire's outcome].

Nishikawa K, Hashimoto N, Tatuki S, Hirano K, Imamichi H.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2002 Oct;37(5):496-504. Japanese.


[Research on factors for dropout from treatment by outpatients of alcohol abuse or alcohol dependence (I)--Based on statements of medical treatment personnel].

Nishikawa K, Hashimoto N, Tatuki S, Hirano K, Imamichi H.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2002 Oct;37(5):485-95. Japanese.


Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii.

Ma L, Kutty G, Jia Q, Imamichi H, Huang L, Atzori C, Beckers P, Groner G, Beard CB, Kovacs JA.

J Infect Dis. 2002 Dec 1;186(11):1647-54. Epub 2002 Nov 11.


Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.

Imamichi H, Igarashi T, Imamichi T, Donau OK, Endo Y, Nishimura Y, Willey RL, Suffredini AF, Lane HC, Martin MA.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13813-8. Epub 2002 Oct 7.


Long-term outcome in 306 males with alcoholism.

Noda T, Imamichi H, Kawata A, Hirano K, Ando T, Iwata Y, Yoneda H.

Psychiatry Clin Neurosci. 2001 Dec;55(6):579-86.


Genetic divergence of the dihydrofolate reductase and dihydropteroate synthase genes in Pneumocystis carinii from 7 different host species.

Ma L, Imamichi H, Sukura A, Kovacs JA.

J Infect Dis. 2001 Nov 15;184(10):1358-62. Epub 2001 Oct 10.


Cause-specific mortality risk among male alcoholics residing in the Osaka metropolitan area.

Noda T, Imamichi H, Tanaka H, Kawata A, Hirano K, Ando T, Yoneda H, Iwata Y, Kinoshita N.

Psychiatry Clin Neurosci. 2001 Oct;55(5):465-72.


Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.

Imamichi H, Crandall KA, Natarajan V, Jiang MK, Dewar RL, Berg S, Gaddam A, Bosche M, Metcalf JA, Davey RT Jr, Lane HC.

J Infect Dis. 2001 Jan 1;183(1):36-50. Epub 2000 Dec 8.


Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression.

Kovacs JA, Imamichi H, Vogel S, Metcalf JA, Dewar RL, Baseler M, Stevens R, Adelsberger J, Lambert L, Davey RT Jr, Walker RE, Falloon J, Polis MA, Masur H, Lane HC.

J Infect Dis. 2000 Oct;182(4):1063-9. Epub 2000 Sep 5.


Advances in understanding the evolution of HIV.

Crandall KA, Vasco DA, Posada D, Imamichi H.

AIDS. 1999;13 Suppl A:S39-47. Review. No abstract available.


An association study between alcoholism and the serotonergic receptor genes.

Himei A, Kono Y, Yoneda H, Sakai T, Koh J, Sakai J, Inada Y, Imamichi H.

Alcohol Clin Exp Res. 2000 Mar;24(3):341-2.


Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen.

de Quiros JC, Shupert WL, McNeil AC, Gea-Banacloche JC, Flanigan M, Savage A, Martino L, Weiskopf EE, Imamichi H, Zhang YM, Adelsburger J, Stevens R, Murphy PM, Zimmerman PA, Hallahan CW, Davey RT Jr, Connors M.

J Virol. 2000 Feb;74(4):2023-8.


High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.

Imamichi T, Sinha T, Imamichi H, Zhang YM, Metcalf JA, Falloon J, Lane HC.

J Virol. 2000 Jan;74(2):1023-8.


[An empirical study on the increase of mild alcoholics in Japan].

Shimizu S, Fujiwara M, Shirasaka T, Sakamoto T, Kato M, Yamana J, Imamichi H, Maeoka K, Ito T, Takemoto T.

Seishin Shinkeigaku Zasshi. 1999;101(5):411-26. Japanese. No abstract available.


Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection.

Crandall KA, Kelsey CR, Imamichi H, Lane HC, Salzman NP.

Mol Biol Evol. 1999 Mar;16(3):372-82.


Cholesterol hydroperoxides in erythrocyte membranes of alcoholic patients.

Adachi J, Asano M, Naito T, Ueno Y, Imamichi H, Tatsuno Y.

Alcohol Clin Exp Res. 1999 Apr;23(4 Suppl):96S-100S.


Abnormality of very long-chain fatty acids of erythrocyte membrane in alcoholic patients.

Adachi J, Miwa A, Ueno Y, Asano M, Naito T, Imamichi H, Tatsuno Y.

Alcohol Clin Exp Res. 1998 May;22(S3 Pt 1):103S-107S.


Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.

Zhang YM, Imamichi H, Imamichi T, Lane HC, Falloon J, Vasudevachari MB, Salzman NP.

J Virol. 1997 Sep;71(9):6662-70.

Supplemental Content

Loading ...
Support Center